Chris Kuehn
Analyst · Vertical Research Partners. Your line is open
Thanks Dave. Please turn to slide number nine. Based on our strong first quarter performance our growing backlog and the expectation for an improving pace of global vaccinations, we have raised our full year guidance for both revenues and adjusted EPS for 2021. As Mike indicated earlier, we expect to deliver strong organic financial performance with organic revenue growth of approximately 9%, up from our previous guidance of between 5% and 7%. We expect to deliver strong organic leverage over 35% for the full year with organic leverage of approximately 30% for the balance of the year. We continue to see about 1.5 points of revenue growth from the channel acquisitions we announced last quarter, which will carry about five points of operating margin and deliver EPS accretion of about $0.05. All in, total revenue growth is expected to be approximately 10.5% and adjusted EPS is expected to be approximately $6 which translates to approximately 35% earnings growth versus 2020. Our updated guidance reflects both our strong performance in Q1 and an improved outlook for the remainder of the year. We also raised our free cash flow guidance with our increased EPS growth. We expect free cash flow to remain strong at equal to or greater than 100% of adjusted net income. If we project current FX rates out to the end of the year, FX would likely be a tailwind, albeit too early to call, given market volatility. Our FX exposure is largely translational and each point of revenue will translate at approximately transitional OI rates. Net, each point from FX would translate into about $0.05 of EPS. Please go to slide number 10. As we outlined during our investor event in December, by transforming Trane Technologies, we initially identified $100 million of fixed cost reductions by 2021. We have exceeded our initial cost reduction expectations, delivering $100 million of savings in 2020, a full year early and we expect to deliver $90 million of incremental savings for a total of $190 million in savings in 2021. We are now targeting and are on track to deliver $300 million of run rate savings by 2023. As we outlined in December, we will continue to invest these cost savings to further strengthen our high-performance flywheel which has a reinforcing and compounding effect over time. First, we invest a significant portion of the savings into unrelenting business reinvestments in innovation and leading technology. This fuels the second element, sustained growth above our end markets. Third, we invest another significant portion of the savings in to an improved the cost structure which drives the fourth element, improved and sustainable incremental margins at or above 25% over the mid to long term. When combined, this creates a compounding effect of high-quality earnings growth and free cash flow year after year. Please go to slide number 11. We remain committed to our balanced capital allocation strategy that is focused on consistently deploying excess cash to opportunities with the highest returns for shareholders. We continue to strengthen our core business with high levels of business reinvestment in high ROI technology, innovation and operational excellence projects which are vital to our continued growth, product leadership and margin expansion. We remain committed to maintaining a strong balance sheet that provides us with continued optionality as our markets evolve. We have a long-standing commitment to a reliable, strong and growing dividend that increases at or above the rate of earnings growth overtime. We continue to pursue strategic M&A that further improves long term shareholder returns and we continue to see value in share repurchases as the stock trades below our calculated intrinsic value. All in, we expect to consistently deploy 100% of excess cash over time. Please turn to slide 12 and I will discuss how we plan to deploy excess cash in 2021. Looking at full year 2021, after fully reinvesting in the business, we plan to continue executing our balanced capital allocation strategy and have increased our capital deployment target to approximately $2.5 billion, a $500 million increase to our prior guidance. We anticipate deploying the additional $500 million between value accretive M&A and share repurchases, taking the total target for M&A and share repurchases to approximately $1.5 billion for the year. In the first quarter, we raised our dividend by 11%, deployed $174 million to M&A and share repurchases and paid down $300 million of debt. We plan to retire an additional $125 million in debt as it reaches maturity in the third quarter of 2021, taking the total debt retirement to $425 million for the year. This guidance increase reflects our strong balance sheet and liquidity position, our commitment to deploying 100% of excess cash over time and our continued confidence in our ability to deliver powerful free cash flow to execute our balanced capital allocation strategy. Now I would like to turn the call back over to Dave and Mike to cover key investor topics of interest and to close with a summary of key points. Dave?